Genetically mediated brain abnormalities in schizophrenia

被引:23
作者
Larry J. Seidman
Heidi E. Wencel
机构
[1] Neuropsychology Laboratory, Massachusetts Mental Health Center, Boston, MA 02115
关键词
Schizophrenia; Schizophrenic Patient; Schizophrenia Patient; Brain Abnormality; Biol Psychiatry;
D O I
10.1007/s11920-003-0030-4
中图分类号
学科分类号
摘要
Schizophrenia is a highly heritable, neurobehavioral disorder; however, the mode of inheritance is complex, and linkage findings have been difficult to replicate. Some consistent linkage findings have emerged on chromosomes 1, 6, 8, 11, 13, 15, and 22. New methods are being developed for candidate gene identification, including the use of neurobiologic phenotypes observed in relatives of persons with schizophrenia. Neuroimaging studies of relatives implicate abnormal hippocampal structure and inefficient prefrontal network functioning, probably representing mild variants of the abnormalities observed in schizophrenia. These characteristics may represent stable markers of vulnerability to schizophrenia, because they are not confounded by effects of antipsychotic drugs or psychosis. Recent studies provide evidence for a small role of the catechol-O-methyltransferase gene on 22q, and the serotonin receptor transporter gene on 17q11-q12 in the development of schizophrenia. Linking genes and brain regions or networks is an important step in identification of the pathophysiology of schizophrenia. Copyright © 2003 by Current Science Inc.
引用
收藏
页码:135 / 144
页数:9
相关论文
共 103 条
[21]  
Harrison P.J., The neuropathology of schizophrenia: A critical review of the data and their interpretation, Brain, 122, pp. 593-624, (1999)
[22]  
Shenton M.E., Dickey C.C., Frumin M., Et al., A review of MRI findings in schizophrenia, Schizophr. Res., 49, pp. 1-52, (2001)
[23]  
McCarley R.W., Wible C.G., Frumin M., Et al., MRI anatomy of schizophrenia, Biol. Psychiatry, 45, pp. 1099-1119, (1999)
[24]  
Hulshoff Pol H.E., Schnack H., Bertens M.G., Et al., Volume changes in gray matter in patients with schizophrenia, Am. J. Psychiatry, 159, pp. 244-250, (2002)
[25]  
Deicken R.F., Johnson C., Pegues M., Proton magnetic resonance spectroscopy of the human brain in schizophrenia, Rev. Neuosci., 11, pp. 147-158, (2000)
[26]  
Crespo-Facorro B., Kim J., Andreasen N.C., Et al., Insular cortex abnormalities in schizophrenia: A structural magnetic resonance imaging study of first-episode patients, Schizophr. Res., 46, pp. 35-43, (2000)
[27]  
Sigmundsson T., Suckling J., Maier M., Et al., Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptoms, Am. J. Psychiatry, 158, pp. 234-243, (2001)
[28]  
Fukuzako H.H., Kodama S., Fukuzako T., Et al., Subtype-associated metabolite differences in temporal lobe in schizophrenia detected by proton magnetic resonance spectroscopy, Psychiatr. Res., 92, pp. 45-56, (1999)
[29]  
Fukuzako H., Fukuzako T., Hashiguichi T., Et al., Changes in levels of phosphorous metabolites in temporal lobs of drug-naive schizophrenic patients, Am. J. Psychiatry, 156, pp. 1205-1208, (1999)
[30]  
Shergill S.S., Cameron L.A., Brammer M.J., Et al., Modality specific neural correlates of auditory and somatic hallucinations, areas involved in the processing of external speech, J. Neurol. Neurosurg. Psychiatry, 71, pp. 688-690, (2001)